Ares Capital Corporation (Nasdaq: ARCC) announced that it has priced its public offering of 14,300,000 shares of its common stock. Ares Capital has granted the underwriters an option to purchase up to an additional 2,145,000 shares of common stock. The offering is subject to customary closing conditions and is expected to close on December 13, 2013. The offering of the shares is being made under Ares Capital’s shelf registration statement (as amended), which was filed with, and declared effective by, the Securities and Exchange Commission. On December 9, 2013, the official close price of Ares Capital’s common stock on The NASDAQ Global Select Market under the symbol “ARCC” was $18.29 per share. Ares Capital expects to use the net proceeds of this offering to repay certain outstanding indebtedness under its debt facilities and, to the extent not used for such purpose, for general corporate purposes, which may include investing in portfolio companies in accordance with its investment objective. Investors are advised to carefully consider the investment objective, risks, charges and expenses of Ares Capital before investing.The preliminary prospectus supplement dated December 9, 2013 and the accompanying prospectus dated June 17, 2013, which have been filed with the Securities and Exchange Commission, contain this and other information about Ares Capital and should be read carefully before investing. Morgan Stanley, BofA Merrill Lynch and Wells Fargo Securities are acting as joint book-running managers for this offering. Deutsche Bank Securities and Goldman, Sachs & Co. are acting as joint lead managers and Barclays, Credit Suisse Securities (USA) LLC, and Keefe, Bruyette & Woods, a Stifel Company, are acting as co-managers for this offering. The underwriters may offer the shares of common stock from time to time for sale in one or more transactions on The NASDAQ Global Select Market, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices.
Before you invest in business development companies (BDCs) holding loans with real estate or other hard assets and mortgage real estate investment trusts (mREITs), understand these differences between the two instruments.